ALEC
Alector Inc
Halal Rating :
Last Price
$1.71
Last updated:
Market Cap
-
7D Change
-4.75%
1 Year Change
-71.34%
Company Overview
Industries
Exchange
Next Earnings Date
Alector is a clinical-stage biopharmaceutical company focused on developing therapies for neurodegenerative diseases and cancer. The company uses its genetic medicine platform and expertise to develop novel therapeutic candidates that target genetic risk factors for these conditions. Their primary focus is on frontotemporal dementia, Alzheimer's disease, and other neurodegenerative disorders.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $15.34m | $63.78m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $15.08m | $60.69m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $15.89m | $59.6m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Alector Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.